CRISPR Therapeutics
CRSP
#2507
Rank
$5.47 B
Marketcap
$68.16
Share price
-2.85%
Change (1 day)
55.44%
Change (1 year)

CRISPR Therapeutics (CRSP) - Cash on Hand

Cash on Hand as of December 2023 : $1.69 B

According to CRISPR Therapeutics's latest financial reports the company has $1.69 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

CRISPR Therapeutics - Cash on Hand chart (from 2015 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$1.69 B-6.7%
2022-12-31$1.81 B-23.7%
2021-12-31$2.37 B40.75%
2020-12-31$1.69 B79.1%
2019-12-31$0.94 B106.67%
2018-12-31$0.45 B90.46%
2017-12-31$0.23 B-24.01%
2016-12-31$0.31 B102.31%
2015-12-31$0.15 B16403.81%
2014-12-31$0.94 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$0.20 B-87.71%๐Ÿ‡บ๐Ÿ‡ธ USA